A weekly e-journal by Art Epstein, OD, FAAO

#########

Volume 10, Number 50

Monday, December 20, 2010

#########


Off the Cuff: Friends, Trends and Loose Ends

I get a real hoot out of some the letters we receive from family and friends this time of year. In that spirit, I thought I would share an Optometric Physician holiday letter with you.

What an odd year this has been. We saw the start of federally sanctioned groping at airports and an election where disenchanted voters changed the very fabric of our government. The economy didn't get any better, and the reality of the depth of our financial problems has really started to sink in. Heathcare reform is now in critical condition, but insurers and bureaucrats haven't noticed the laser target aimed at their hearts just yet.

Personally, this was a year where I've rediscovered the meaning of true friendship; the kind where people stick with you when thick turns to thin. I've come to appreciate old friends all the more and I better comprehend how stark the contrast is between decency and malice. I figured out that doing the right thing is not always easy and that honesty is still the best policy, but apparently not everyone agrees. I've witnessed politics at its worst, but I've also learned the virtue of patience and the value of listening and seeking counsel.

Optometry in 2010 reflected turmoil and dissention. Our profession remains fragmented and many feel angry and disenfranchised. Yet despite all of this angst, I see glimmers of hope starting to emerge from the fog of discord.

2010 was a banner year for new drugs and flopped launches. An absurd and perverse regulatory environment has made it increasingly difficult to care for our patients. Sadly, appreciating just how good the good old days were has less and less to do with my age.

This is the last issue of 2010. I wish all of you joyful and peaceful holidays and I look forward to sharing a much better 2011 with you. Thank you for your friendship, your support and for welcoming me into your homes and offices every week.

Arthur B. Epstein, OD, FAAO
Chief Medical Editor
[email protected]

 



Want to share your perspective? Write to Dr. Epstein at [email protected]. Comments received may be published on OP-Blog at the discretion of the editor without attribution. Please indicate if you would like your thoughts attributed to you.

The views expressed in this editorial are solely those of the author and do not necessarily represent the opinions of the editorial board, Jobson Publishing or any other entities or individuals.

 







Only one vote allowed per person. All votes register immediately and will be displayed in real-time. If you feel passionate about this issue, read what your colleagues are saying or express your comments directly by visiting  http://blog.voiceoftheprofession.com/. —Dr. Mike Mayers

Pigment Deposition of Cosmetic Contact Lenses on the Cornea After Intense Pulsed-Light Treatment
 
 
A 30-year-old female presented with ocular pain and epiphora in both eyes. These symptoms developed after she had undergone facial intense pulsed-light (IPL) treatment. She was wearing cosmetic contact lenses throughout the IPL procedure.

At presentation, her uncorrected visual acuity was 20/200 in both eyes, and the slit-lamp examination revealed deposition of the color pigment of the cosmetic contact lens onto the corneal epithelium. The corneal epithelium was scraped using a no. 15 blade. Seven days after the procedure, the corneal epithelium had healed without any complications.

This case highlights the importance of considering the possibility of ocular complications during IPL treatment, particularly in individuals using contact lenses. To prevent ocular damage, IPL procedures should be performed only after removing the lenses and applying eyeshields.

SOURCE: Hong S, Lee JR, Lim T. Pigment deposition of cosmetic contact lenses on the cornea after intense pulsed-light treatment. Korean J Ophthalmol 2010;24(6):367–70.


Acupuncture Reduces Symptoms of Dry Eye Syndrome
 
 
The aim of this study was to evaluate the effect of acupuncture treatment on dry eye syndrome. This was a prospective observational study conducted at a clinical evaluation center for acupuncture and moxibustion of the Korean Institute of Oriental Medicine. The subjects were patients with dry eye disease (n = 36), defined by Schirmer test scores of <10 mm/5 min and tear film break-up times (BUTs) of <10 seconds. Participants were treated with acupuncture three times per week for four weeks. Schirmer test scores, BUTs, symptom scores, ocular surface disease index (OSDI) scores and dry eye symptom questionnaires were compared before and after treatment to evaluate the efficacy of acupuncture treatment.

After treatment, symptom scores, OSDI scores and the number of dry eye symptoms were all significantly lower. Although tear wettings were significantly higher, there were no significant differences in BUTs.

This study suggests that acupuncture treatment can effectively relieve the symptoms of dry eye and increase watery secretion.

SOURCE: Jeon JH, Shin MS, Lee MS, et al. Acupuncture reduces symptoms of dry eye syndrome: a preliminary observational study. J Altern Complement Med 2010;16(12):1291–1294.

Characterization of Peripapillary Atrophy Using Spectral Domain Optical Coherence Tomography
 
 
Spectral domain optical coherence tomography (SD-OCT) imaging of the optic disc was performed on healthy eyes, eyes suspected of having glaucoma and eyes diagnosed with glaucoma to characterize peripapillary atrophy (PPA) zones in glaucomatous eyes. From the peripheral β-zone, the retinal nerve fiber layer (RNFL), the junction of the inner and outer segments (IS/OS) of the photoreceptor layer, and the Bruch's membrane/retinal pigment epithelium complex layer (BRL) were visualized.

Nineteen consecutive eyes of ten subjects were imaged. The RNFL was observed in the PPA β-zone of all eyes, and no eye showed an IS/OS complex in the β-zone. The BRL was absent in the β-zone of two eyes. The BRL was incomplete or showed posterior bowing in the β-zone of five eyes.

The common findings in the PPA β-zone were that the RNFL was present, but the photoreceptor layer was absent. Presence of the BRL was variable in the β-zone areas.

SOURCE: Na JH, Moon BG, Sung KR, Lee Y, Kook MS. Characterization of peripapillary atrophy using spectral domain optical coherence tomography. Korean J Ophthalmol 2010;24(6):353–359.



Christmas in Arizona—For those of you who wonder what winter in Arizona is like. Click here to download a large version of this image. -AE


News & Notes
 
ALCON-NOVARTIS MERGER OFFERS EXPANDED OPPORTUNITIES. In a recent press release, Alcon, Inc. announced that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own.

The merger, which is expected to be completed during the first half of 2011, will be effected under Swiss merger law and is conditional, among other things, on two-thirds approval by the shareholders of both Novartis and Alcon voting at their respective meetings. Upon completion of the merger, Alcon will become the second largest division within Novartis. CIBA VISION and select Novartis ophthalmic medicines will be integrated into Alcon, forming an organization with more than $8.7 billion in sales covering over 70 percent of the eye care segment. According to Alcon, the new eye care division will combine the company's in-depth scientific knowledge of eye disease and clinical experience with the broad-based research capabilities and resources of Novartis, allowing for an expanded commitment to research and development activities in eye care.
 
NEW COMPACT GONIO LENS FROM VOLK. Now available is Volk Optical's new Mini 4 Mirror Gonio Lens, which, according to Volk, delivers complete angle views. The Mini 4 Mirror offers a full view of the chamber angle at 1.0x magnification with a slight lens rotation and the small body and ring make for easy manipulation of the lens, especially within a small orbit. The company says that its newest lens is an excellent complement to a standard 4 mirror Gonio lens, offering additional flexibility with a smaller body. For more information, visit www.volk.com.
 
SANTEN LAUNCHES NEW DRY EYE TREATMENT IN JAPAN. Santen Pharmaceutical Co., Ltd. has launched its new dry eye treatment, DIQUAS Ophthalmic Solution 3% (diquafosol sodium) in Japan. The drug has a new mechanism of action for dry eye that was licensed for certain ophthalmic uses from Inspire Pharmaceuticals, Inc. and developed by Santen. Clinical studies conducted in Japan showed that DIQUAS improved dry eye symptoms by promoting secretion of mucin and water as main components of tears, thereby bringing the tear film closer to a normal state. No serious ocular or systemic adverse drug reactions were found during the clinical trials. Read more here.
 
   

 


Optometric Physician™ Editorial Board
 

Chief Medical Editor
Arthur B. Epstein, OD, FAAO

Journal Reviews
Shannon Steinhäuser, OD, FAAO

Editor
Karen Rodemich

Art/Production Director
Joe Morris

Contributing Editors
• Katherine M. Mastrota, MS, OD, FAAO
• Michael Mayers, OD, FAAO
• Barry A. Weissman, OD, PhD, FAAO (Dip CL)

Editorial Board
• William Jones, OD, FAAO
• Alan G. Kabat, OD, FAAO
• Bruce Onofrey, RPh, OD, FAAO
• John Schachet, OD, FIOS
• Joseph Shovlin, OD, FAAO


 

 

HOW TO SUBMIT NEWS
E-mail [email protected] or FAX your news to: 610.492.1039.

HOW TO ADVERTISE
For information on advertising in this e-mail newsletter or other creative advertising opportunities with Optometric Physician, please contact sales managers James Henne ( [email protected]), Michele Barrett ( [email protected]), or Kimberly McCarthy ( [email protected]).

Optometric Physician is published by Jobson Professional Publications Group, a division of Jobson Medical Information LLC, 11 Campus Blvd., Newtown Square, PA 19073.

HOW TO CHANGE YOUR SUBSCRIPTION
To change your subscription, reply to this message and give us your old address and your new address; type "Change of Address" in the subject line. If you do not want to receive Optometric Physician, click here. If you enjoy reading Optometric Physician, please tell a friend or colleague about it. Or go to: www.jobson.com/globalemail/ to sign up for a free subscription to Optometric Physician.